0001641489-24-000051.txt : 20240627
0001641489-24-000051.hdr.sgml : 20240627
20240627164022
ACCESSION NUMBER: 0001641489-24-000051
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240625
FILED AS OF DATE: 20240627
DATE AS OF CHANGE: 20240627
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SPIEGELMAN DANIEL K
CENTRAL INDEX KEY: 0001238403
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37524
FILM NUMBER: 241079836
MAIL ADDRESS:
STREET 1: MYRIAD GENETICS
STREET 2: 322 NORTH 2200 WEST
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84116
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: vTv Therapeutics Inc.
CENTRAL INDEX KEY: 0001641489
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 473916571
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3980 PREMIER DR
STREET 2: SUITE 310
CITY: HIGH POINT
STATE: NC
ZIP: 27265
BUSINESS PHONE: 336-841-0300
MAIL ADDRESS:
STREET 1: 3980 PREMIER DR
STREET 2: SUITE 310
CITY: HIGH POINT
STATE: NC
ZIP: 27265
FORMER COMPANY:
FORMER CONFORMED NAME: VTV Therapeutics Inc.
DATE OF NAME CHANGE: 20150506
4
1
wk-form4_1719520815.xml
FORM 4
X0508
4
2024-06-25
0
0001641489
vTv Therapeutics Inc.
VTVT
0001238403
SPIEGELMAN DANIEL K
C/O VTV THERAPEUTICS INC.
3980 PREMIER DRIVE, SUITE 310
HIGH POINT
NC
27265
1
0
0
0
0
Director stock option (right to buy)
17.22
2024-06-25
4
A
0
6000
17.22
A
2034-06-25
Class A Common Stock
6000
6000
D
The options will vest monthly over the three year period following date of grant.
/s/ Paul J. Sekhri as Attorney-in-Fact
2024-06-27